A Study to Assess the Absolute Bioavailability of Empasiprubart SC Administered With an Autoinjector and the Pharmacokinetic Noninferiority of Empasiprubart SC Versus Intravenous (IV) in Healthy Adult Participants

Clinical trial NCT07612020 · RECRUITING

Trial details

NCT number: NCT07612020
Sponsor: argenx
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2026-03-16
Primary completion: 2027-03-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.